KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Long-Term Debt Repayments: 2013-2022

Historic Long-Term Debt Repayments for Travere Therapeutics (TVTX) over the last 3 years, with Mar 2022 value amounting to $211.3 million.

  • Travere Therapeutics' Long-Term Debt Repayments was N/A to $211.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $251.6 million, marking a year-over-year change of. This contributed to the annual value of $211.3 million for FY2022, which is N/A change from last year.
  • Per Travere Therapeutics' latest filing, its Long-Term Debt Repayments stood at $211.3 million for Q1 2022, which was up 432.26% from $39.7 million recorded in Q3 2018.
  • Travere Therapeutics' Long-Term Debt Repayments' 5-year high stood at $211.3 million during Q1 2022, with a 5-year trough of $500,000 in Q2 2018.
  • In the last 1 years, Travere Therapeutics' Long-Term Debt Repayments had a median value of $211.3 million in 2022 and averaged $211.3 million.
  • Data for Travere Therapeutics' Long-Term Debt Repayments shows a peak YoY skyrocketed of 15,781.20% (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Travere Therapeutics' Long-Term Debt Repayments stood at $39.7 million in 2018, then followed by $211.3 million in 2022.
  • Its last three reported values are $211.3 million in Q1 2022, $39.7 million for Q3 2018, and $500,000 during Q2 2018.